NWFAF yields 105263.16% · PFE yields 6.13%● Live data
📍 NWFAF pulled ahead of the other in Year 1
Combined, NWFAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NWFAF + PFE for your $10,000?
New Focus Auto Tech Holdings Limited, an investment holding company, engages in the manufacture and sale of electronic and power-related automotive parts and accessories. The company operates in two segments, Manufacturing Business; and Automobile Dealership and Service Business. It offers automotive lighting and automotive electronic power products, including the automotive converter boxes, multi-function power supplies, cooler and warmer boxes, chargers, automotive lighting products high intensity discharge lamps, automotive auxiliary lights, work lights, etc. The company is also involved in the provision of after-sales services, including maintenance and repair, automobile customization and furnishing, and automobile recall and consultancy services; distribution of automobile insurance and financial products; and sale of automobile accessories. It has operations in the People's Republic of China, the Americas, Europe, and the Asia Pacific. New Focus Auto Tech Holdings Limited was incorporated in 2002 and is headquartered in Shanghai, the People's Republic of China.
Full NWFAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.